C
Chris Smith
Guest
- A promising drug being developed to treat COVID-19 failed to show efficacy with severe coronavirus cases.
- Eli Lilly announced that it has terminated a study evaluating the efficacy of the monoclonal antibody drug in hospitalized patients.
- ”Bamlanivimab [LY-CoV555] is unlikely to help hospitalized COVID-19 patients recover from this advanced stage of their disease,” the company said in its announcement.
- Lilly continues to study the drug in other trials and has already requested an emergency use authorization to treat mild to moderate cases of COVID-19.
New coronavirus cases are surging yet again, and thousands of people are dying every week. But the world has come a long way since the early days of the pandemic when it comes to treatments. The virus is spreading like wildfire, as many people are failing to observe the safety measures that can reduce transmission. The more people get infected, the more people will die. But doctors are able to save more lives than before thanks to some therapies that can prevent COVID-19 complications and speed up recovery.
In search of a coronavirus cure, researchers have taken one of the three possible avenues. Some came up with vaccine candidates, and a vaccine might be available to at-risk people by the end of the year. Others repurposed existing drugs for COVID-19 — remdesivir, dexamethasone, and blood thinners are examples that have shown a degree of efficacy. And others are developing brand new drugs, including a type of medicine that should work quite well against the new pathogen. Those are the monoclonal antibody drugs that act much like a very potent plasma transfusion, offering the recipient a high dose of neutralizing antibodies that should block the virus from infecting cells. Monoclonal antibodies can clear the virus or even theoretically provide temporary coronavirus immunity to healthy people. But as promising as these drugs might sound, we’ve just learned they have limitations, and they might not work in the cases that matter most.
Continue reading...
Today's Top Deals
- The 5 best deals in today’s early Amazon Black Friday 2020 sale
- 3M face masks on Amazon haven’t been this cheap since the start of the pandemic
- Why pay $250+ for a box of 3M N95 masks when these work better for $1.89 each?
Trending Right Now:
- Too many people are ignoring one of the easiest ways to catch COVID-19, Dr. Fauci says
- Dr. Fauci is finally fed up with Trump’s continued attacks over coronavirus
- This breakthrough could be a huge turning point for the coronavirus pandemic
We have bad news about one of the most promising new coronavirus drugs originally appeared on BGR.com on Tue, 27 Oct 2020 at 10:25:10 EDT. Please see our terms for use of feeds.
Via BRG - Boy Genius Report